Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 avr. 2025 09h12 HE | Source: Albatroz Therapeutics

Nature Communications Publishes Pivotal Data From Albatroz Therapeutics Demonstrating That Inhibiting Calnexin Alleviates Arthritis Symptoms and May Reverse Disease Progression

Nature study uncovers insights about the progression of osteoarthritis (OA) and rheumatoid arthritis; demonstrates therapeutic approach targeting Calnexin.
26 mars 2025 15h00 HE | Source: Custom Market Insights

[Latest] Global Fabry Disease Treatment Market Size/Share Worth USD 7.02 Billion by 2034 at a 9.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, March 27, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Fabry Disease Treatment Market Size, Trends and Insights By Treatment (Enzyme...
19 déc. 2024 06h27 HE | Source: Introspective Market Research

Clinical Trial Outsourcing Market Expected To Reach USD 111.01 Billion by 2032, Growing at a CAGR of 8.7% From 2024-2032 | Introspective Market Research

United Kingdom, London, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Australian healthcare technology company Resonance Health completed the acquisition of 100% of clinical research center TrialsWest for a...
10 déc. 2024 11h30 HE | Source: Custom Market Insights

[Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 21,413.4 Million by 2033 at a 5.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Gastrointestinal Endoscopy Devices Market Size, Trends and Insights By Product...
21 nov. 2024 09h24 HE | Source: Purdue Research Foundation

Eradivir’s EV25 therapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies

WEST LAFAYETTE, Ind., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Eradivir, a preclinical biotech company that licenses innovations from Purdue Research Foundation, has developed a patent-pending antiviral...
12 nov. 2024 14h30 HE | Source: Custom Market Insights

[Latest] Global Dental Digital X-ray Market Size/Share Worth USD 6.7 Billion by 2033 at a 7.68% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Dental Digital X-ray Market Size, Trends and Insights By Product (Digital X-ray...
06 nov. 2024 13h00 HE | Source: Custom Market Insights

[Latest] Global Cancer Cell Analysis Market Size/Share Worth USD 23.31 Billion by 2033 at a 8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Cell Analysis Market Size, Trends and Insights By Application (Cancer...
01 nov. 2024 16h30 HE | Source: Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split

Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
15 oct. 2024 05h00 HE | Source: Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform

Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform
14 oct. 2024 06h02 HE | Source: GEn1E Lifesciences Inc.

GEn1E Lifesciences Publishes Breakthrough Research Unveiling Novel Mechanism of Action of Dual Signal Modulators for Anti-inflammatory and Endothelial-Stabilizing Therapies

GEn1E Lifesciences today announced the publication of a landmark study in the prestigious Journal of Pharmacology and Experimental Therapeutics (JPET)

Page suivante keyboard_arrow_right